Aging, antiretrovirals, and adherence: A meta analysis of adherence among older hiv-infected individuals

Drugs and Aging

Volumn 30, Issue 10, 2013, Pages 809-819

  Ghidei, Luwam ^a   Simone, Mark J ^c,e   Salow, Marci J ^b   Zimmerman, Kristin M ^b,d   Paquin, Allison M ^b   Skarf, Lara M ^b,e   Kostas, Tia R M ^b,c,e   Rudolph, James L ^b,c,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

AGING; ANTIVIRAL THERAPY; CROSS-SECTIONAL STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; RISK REDUCTION; SELF REPORT; SYSTEMATIC REVIEW;

AGE DISTRIBUTION; AGE FACTORS; AGED; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE;

EID: 84890175405     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0107-7     Document Type: Review

References (50)

1. Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;2012(102):1516-26.
2. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2010; vol. 22. http://www.cdc.gov/hiv/pdf/statistics-surveillance-report-vol-22. pdf (Accessed 20 July 2012).
3. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2011; vol. 23. http://www.cdc.gov/hiv/topics/surveillance/resources/reports (Accessed 10 Dec 2012).
4. Center for Disease Control and Prevention. HIV/AIDS among persons aged 50 and older; 2008. http://www.cdc.gov/hiv/topics/over50/ (Accessed 20 July 2012).
5. Collaboration TATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-9. (Pubitemid 352020438)
6. Abrass CK, Appelbaum JS, Boyd CM, Braithwaite RS, Broudy VC, Covinsky K, et al. HIV and aging consensus project; recommended treatment strategies for clinicians managing older patients with HIV. J Am Geriatr Soc. 2012;60:974-9.
7. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30. (Pubitemid 30432540)
8. Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3:453-72.
9. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261-8. (Pubitemid 38280651)
10. Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretroviral in HIV-infected patients. HIV Clin Trials. 2002;3:371-8. (Pubitemid 35189880)
11. Dunham PJ, Karkula JM. Effects of a pharmacy-care program on adherence and outcomes. Am J Pharm Benefits. 2012;4:e8-14.
12. Viswanathan H, Anderson R, Thomas Iii J. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care STDS. 2005;19:306-16. (Pubitemid 40770654)
13. Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract. 2008;22:114-47.
14. Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17:645-56. (Pubitemid 38031552)
15. Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004). J Acquir Immune Defic Syndr. 2007;44:20-9. (Pubitemid 46052216)
16. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40-9. (Pubitemid 46072023)
17. Cuzin L, Delpierre C, Gerard Sp, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged 150 years. Clin Infect Dis. 2007;45:654-7. (Pubitemid 47328650)
18. Sherr L, Harding R, Lampe F, Johnson M, Anderson J, Zetler S, et al. Clinical and behavioural aspects of aging with HIV infection. Psychol Health Med. 2009;14:273-9.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. (Pubitemid 30214957)
20. Elema R, Mills C, Yun O, Lokuge K, Ssonko C, Nyirongo N, et al. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. J Int Assoc Physicians AIDS Care (Chic). 2009;8:60-7.
21. Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. HIV Med. 2013 (Epub ahead of print).
22. Mills EJ, Nachega JB, Buchan I, Orbinski J, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679-90. (Pubitemid 44200639)
23. U.S. Preventive Services Task Force Procedure Manual. AHRQ Publication No. 08-05118-EF; 2008. http://www.uspreventiveservicestaskforce.org/uspstf08/ methods/procmanual.htm (Accessed 10 July 2012).
24. Higgins J. Heterogeneity in meta-analyses should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158-60.
25. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2008.
26. Lyimo R, van den Boogarden J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:1-20.
27. Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601-11.
28. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19-25.
29. Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684-91. (Pubitemid 46598461)
30. Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939-45.
31. Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63:6-12.
32. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92. (Pubitemid 32115053)
33. Dowshen N, D'Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762-71.
34. Greene M, Justice AC, Valcour V, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397-405.
35. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7:69-76.
36. Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1-18.
37. Johnson CJ, Heckman TG, Hansen NB, et al. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care Psychol Soc Med Aspects AIDS/HIV. 2009;21(5):541-51.
38. Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:1-32. (Pubitemid 39615382)
39. Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235-44. (Pubitemid 46651251)
40. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9:11-23.
41. Ladefoged K, Andersson M, Koch A, et al. Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients. Int J Circumpolar Health. 2012;71:1-8.
42. Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15:1397-409.
43. Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr. 2010;55:221-4.
44. Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, et al. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002;35:1173-81. (Pubitemid 36018693)
45. Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc. 2002;50:603-7. (Pubitemid 34298746)
46. Watt MH, Maman S, Golin CE, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22:381-9.
47. Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve HIV patients. HIV Clin Trials. 2011;12:244-54.
48. Fletcher M, Brundage R, Chesney M, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. J Acquir Immune Defic Syndr. 2005;40:301-6. (Pubitemid 41533070)
49. Manfredi R, Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14:1475-7. (Pubitemid 30459534)
50. Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185-94.